Does early diagnostic ILR application allow safe and effective therapy in patients with recurrent suspected neurally mediated syncope?
Early application of an implantable loop recorder with delayed therapy until syncope documentation is a safe and effective strategy for patients with suspected neurally mediated syncope.
A strategy based on early diagnostic ILR application, with therapy delayed until documentation of syncope allows a safe, specific, and effective therapy in patients with NMS.
Brignole et al. (Tue,) studied this question.